Drug Type Small molecule drug |
Synonyms- |
Mechanism 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), ADRA2 antagonists(Adrenergic receptors alpha-2 antagonists), ADRA2B agonists(Alpha-2b adrenergic receptor agonists) + [3] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H21N |
InChIKeyJURKNVYFZMSNLP-UHFFFAOYSA-N |
CAS Registry303-53-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Low Back Pain | Phase 3 | BR | 01 May 2012 |